News
Jasper Therapeutics, Inc.’s JSPR share price has surged by 7.55%, which has investors questioning if this is right time to sell.
According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal ...
Joan Smith spent almost 40 years believing she suffered from severe allergies. Medical professionals frequently dismissed her ...
Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.
The following is a summary of “Prevalence of Mast Cell Activation Disorders and Hereditary Alpha Tryptasemia Amongst POTS and ...
Because of the often nonspecific nature of MCL, diagnostic efforts need to be better streamlined to reduce the risk of misdiagnosis.
Learn more about whether Blueprint Medicines Corporation or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your ...
Raquel Rodriguez has lost many months of her WWE career due to her skin condition flaring up at very inopportune times. RAW ...
Raquel Rodriguez recently opened up about a skin condition during an interview on INSIGHT with Chris Van Vliet.
Readers reply to an essay on overdiagnosis in medicine.
Arcus Biosciences Inc. has disclosed mast/stem cell growth factor receptor Kit (KIT; c-Kit; CD117) inhibitors reported to be useful for the treatment of cancer, allergy, autoimmune, inflammatory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results